NightHawk Biosciences Announces Planned Name Change to Scorp

NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO

Announces senior leadership appointments to further support client programs and growing sales pipelineDURHAM, N.C., Jan. 08, 2024 -- NightHawk Biosciences , an integrated contract development and...

Related Keywords

Texas , United States , Lagos , Nigeria , Warsaw , L67 , Poland , San Antonio , American , Brian Omara , Jeff Wolf , Catalent Biologics , Ania Szymanska , Steve Lavezoli , David Waldman , Marker Therapeutics Inc , Quality Validation Specialists Of Opexa Therapeutics Inc , Company To Scorpius Holdings Inc , Quality Control For Bellicum Pharmaceuticals Inc , University Of Warsaw , Bristol Myers Squibb , Business Market Development , Suspension Process Development At Rocket Pharmaceuticals , Quality Control Department , Scorpius Holdings , Twitter , Robert Morris University , Lehigh University , Manufacturing Science Technology , Binghamton University , Rutgers University , Business Development , Pennsylvania State University , Woodfield Pharmaceutical , Nighthawk Biosciences Inc , Pernix Manufacturing , Drug Substance Business Development , Hawk Biosciences , Scorpius Biomanufacturing , Briano Mara , Process Sciences , Commercial Operations , Juan Lagos , Senior Director , Cell Based Technologies , Site Head , Manufacturing Science , Linde Gas , Startup Biopharmaceutical , Market Development , Bulk Drug Substance Single Use , Chemical Engineering , Robert Morris , Associate Director , Process Development , Wuxi Apptec , Computer Science , Quality Control , Quality Assurance , Marker Therapeutics , Vice President , Quality Management , Bellicum Pharmaceuticals , Quality Validation Specialists , Opexa Therapeutics , Private Securities Litigation Reform Act , Investor Relations , Markets ,

© 2025 Vimarsana